NO971358L - Racermiserings- og asymmetriske transformeringsfremgangsmåter anvendt ved fremstilling av levobupivacain og analoger derav - Google Patents

Racermiserings- og asymmetriske transformeringsfremgangsmåter anvendt ved fremstilling av levobupivacain og analoger derav

Info

Publication number
NO971358L
NO971358L NO971358A NO971358A NO971358L NO 971358 L NO971358 L NO 971358L NO 971358 A NO971358 A NO 971358A NO 971358 A NO971358 A NO 971358A NO 971358 L NO971358 L NO 971358L
Authority
NO
Norway
Prior art keywords
pct
compound
racizing
levobupivacaine
analogs
Prior art date
Application number
NO971358A
Other languages
English (en)
Other versions
NO308074B1 (no
NO971358D0 (no
Inventor
Ulrich Conrad Dyer
Christopher James Lock
Martin Woods
Original Assignee
Chiroscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9504927.6A external-priority patent/GB9504927D0/en
Application filed by Chiroscience Ltd filed Critical Chiroscience Ltd
Publication of NO971358D0 publication Critical patent/NO971358D0/no
Publication of NO971358L publication Critical patent/NO971358L/no
Publication of NO308074B1 publication Critical patent/NO308074B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B53/00—Asymmetric syntheses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B55/00—Racemisation; Complete or partial inversion

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measurement Of Radiation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO971358A 1994-09-23 1997-03-21 FremgangsmÕte for racemisering av optiske anrikete heterocykliske karboksanilider NO308074B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP94306962 1994-09-23
GBGB9504927.6A GB9504927D0 (en) 1995-03-10 1995-03-10 Racemisation and asymmetric transformation
PCT/GB1995/002247 WO1996009290A1 (en) 1994-09-23 1995-09-22 Racemisation and asymmetric transformation processes used in the manufacture of levobupivacaine and analogues thereof

Publications (3)

Publication Number Publication Date
NO971358D0 NO971358D0 (no) 1997-03-21
NO971358L true NO971358L (no) 1997-03-21
NO308074B1 NO308074B1 (no) 2000-07-17

Family

ID=26137306

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971358A NO308074B1 (no) 1994-09-23 1997-03-21 FremgangsmÕte for racemisering av optiske anrikete heterocykliske karboksanilider

Country Status (18)

Country Link
US (1) US5786484A (no)
EP (1) EP0782569B1 (no)
JP (1) JP3898220B2 (no)
KR (1) KR100393133B1 (no)
CN (1) CN1104416C (no)
AT (1) ATE214695T1 (no)
AU (1) AU695479B2 (no)
CA (1) CA2200490C (no)
DE (1) DE69525950T2 (no)
DK (1) DK0782569T3 (no)
ES (1) ES2173194T3 (no)
FI (1) FI117436B (no)
HU (1) HU216291B (no)
MX (1) MX9702210A (no)
NO (1) NO308074B1 (no)
PL (1) PL183204B1 (no)
PT (1) PT782569E (no)
WO (1) WO1996009290A1 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6384227B2 (en) 1995-01-18 2002-05-07 Darwin Discovery Ltd. Racemisation process for use in the manufacture of levobupivacaine and related piperidinecarboxanilide anaesthetic agents
JP2000256359A (ja) * 1999-03-11 2000-09-19 Japan Science & Technology Corp 面性キラリティーを有する分子群の高選択的不斉変換法
US6288280B1 (en) * 1999-07-09 2001-09-11 Hoffmann-La Roche Inc. Racemization of atropisomeric bis(phosphine oxide) compounds
BR0002246A (pt) * 2000-04-06 2003-04-15 Cristalia Prod Quimicos Farm Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis
WO2001096301A1 (fr) 2000-06-14 2001-12-20 Toray Industries, Inc. Procedes de production de derive de piperidine racemique et de production de derive de piperidine a activite optique
DE10029851A1 (de) * 2000-06-16 2001-12-20 Boehringer Ingelheim Pharma Enantiomerentrennung von Piperidon-Derivaten unter gleichzeitiger in situ Racemisierung des unerwünschten Enantiomers
US6495694B2 (en) 2000-06-16 2002-12-17 Boehringer Ingelheim Pharma Kg Efficient separation of enantiomers of piperidone derivatives by precipitation of the desired eantiomer during in situ racemization of the unwanted enantiomer
BRPI0104491B8 (pt) * 2001-10-10 2021-05-25 Cristalia Produtos Quim Farmaceuticos Ltda n-(2,6-dimetilfenil)-1-propil-2-piperidinocarboxamida; processo de obtenção dos enantiômeros; mistura não racêmica dos anantiômeros e seu processo de obtenção e composição farmacêutica.
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
ES2350689T3 (es) 2002-12-13 2011-01-26 Durect Corporation Sistema de suministro de fármacos oral que comprende materiales vehículo líquidos de alta viscosidad.
WO2006033948A2 (en) 2004-09-17 2006-03-30 Durect Corporation Sustained local anesthetic composition containing preferably a sugar ester such as saib
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
WO2008066642A2 (en) 2006-11-03 2008-06-05 Durect Corporation Transdermal delivery systems comprising bupivacaine
JP2011506318A (ja) 2007-12-06 2011-03-03 デュレクト コーポレーション 経口医薬製剤
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
CN102093284B (zh) * 2010-12-29 2013-05-08 宜昌人福药业有限责任公司 富集哌啶-2-甲酰苯胺类旋光化合物的方法
WO2014144975A1 (en) 2013-03-15 2014-09-18 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
CN103664744B (zh) * 2013-11-30 2015-07-15 山东永泰化工有限公司 一种左布比卡因的制备方法
KR20210039987A (ko) * 2018-05-18 2021-04-12 쿠라 온콜로지, 인크. 티피파닙의 합성
JP2023515918A (ja) 2020-01-13 2023-04-17 デュレクト コーポレーション 不純物が低減された徐放性薬物送達システム及び関連の方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE451840B (sv) * 1986-01-03 1987-11-02 Astra Laekemedel Ab Optiskt rent monohydrat av s-(-)-1-propyl-2',6'-pipekoloxylididhydroklorid, sett att framstella denna och farmaceutiska beredningar for lokalbedovning

Also Published As

Publication number Publication date
NO308074B1 (no) 2000-07-17
EP0782569A1 (en) 1997-07-09
FI971202A (fi) 1997-03-21
CA2200490A1 (en) 1996-03-28
HUT77055A (hu) 1998-03-02
FI971202A0 (fi) 1997-03-21
PT782569E (pt) 2002-09-30
HU216291B (hu) 1999-06-28
CN1104416C (zh) 2003-04-02
ES2173194T3 (es) 2002-10-16
US5786484A (en) 1998-07-28
DK0782569T3 (da) 2002-07-22
MX9702210A (es) 1998-05-31
AU3527995A (en) 1996-04-09
CN1159184A (zh) 1997-09-10
NO971358D0 (no) 1997-03-21
CA2200490C (en) 2007-01-09
JPH10505855A (ja) 1998-06-09
DE69525950T2 (de) 2002-09-19
PL319368A1 (en) 1997-08-04
DE69525950D1 (de) 2002-04-25
AU695479B2 (en) 1998-08-13
PL183204B1 (pl) 2002-06-28
ATE214695T1 (de) 2002-04-15
WO1996009290A1 (en) 1996-03-28
FI117436B (fi) 2006-10-13
JP3898220B2 (ja) 2007-03-28
EP0782569B1 (en) 2002-03-20
KR100393133B1 (ko) 2003-11-17

Similar Documents

Publication Publication Date Title
NO971358L (no) Racermiserings- og asymmetriske transformeringsfremgangsmåter anvendt ved fremstilling av levobupivacain og analoger derav
DE69531624D1 (de) Verfahren zur herstellung von levobupivacaine und analoge
NO20006645L (no) Ny form av irbesartan, fremgangsmåte for å oppnå den nevnte form og farmasöytiske preparater inneholdende den samme
NO964346D0 (no) Fremgangsmåte for opplösning av Etodolac ved bruk av glukaminderivater
PT87294A (pt) Process for the preparation of 17beta-(cyclopropylamino)-androst-5-en-3beta-ol and related compounds useful as c17-20 lyase inhibitors and of pharmaceutical compositions containing the same
DE69824839D1 (de) Verfahren zur herstellung von 2-aryl-3-aryl-5-halogen-pyridinen, verwendbar als cox-2 inhibitoren
ATE182879T1 (de) Neuartig substituierte dtpa-derivate, deren metallkomplexe, diese komplexe enthaltende pharmazeutische mittel, deren verwendung in der diagnostik und therapie, sowie verfahren zur herstellung der komplexe und mittel
ATE111455T1 (de) 3-substituierte 1,2,3,4-oxatriazol-5- iminderivate, verfahren zur herstellung sowie diese enthaltende arzneimittel.
SE9501808D0 (sv) New process
DE69606411T2 (de) Verfahren zur herstellung von liponsaeure
ATE207880T1 (de) Verfahren zur herstellung von kontrastmitteln
ATE212019T1 (de) Verfahren zur herstellung von phenylheterocyclen die als cox-2 inhibitoren verwendet werden können
ATE339423T1 (de) Verfahren zur herstellung von 4'-o-substituierten 4'-demethyl-1 desoxypodophyllotoxinderivaten und geometrischen isomeren davon ,und antikrebspräparat, das diese enthält
DK0808306T3 (da) Hidtil ukendte pyridin- eller pyridazinderivater, fremgangsmåder til fremstilling deraf og lægemidler indeholdende disse fo
DE50104847D1 (de) Verfahren zur herstellung chiraler verbindungen
DE69514512T2 (de) Verfahren zur herstellung von benzopyranderivaten
DE59504643D1 (de) Neue phosphanoxide, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
DK0784603T3 (da) Racemisering af forstadier for levobupivacain og analoge forstadier heraf

Legal Events

Date Code Title Description
MK1K Patent expired